New biomarker combo could slash unnecessary antibiotics in NICU babies
NCT ID NCT03299751
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 36 times
Summary
This study looked at 233 newborns in intensive care to find a combination of blood tests that can quickly and accurately diagnose late-onset sepsis. Sepsis is hard to spot in newborns, leading to too many antibiotics being given. The goal was to identify a test that rules out infection early, so only babies who truly need antibiotics get them.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LATE-ONSET NEONATAL SEPSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de Nantes
Nantes, France
-
Hospices Civils de Lyon
Bron, 69500, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.